theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Internal Medicine

Journal Club ft. NEJM publications   

Questions discussed in this category


What is your preferred frontline treatment for CLL in young patients < 50 years old?
5 Answers available
7190


Papers discussed in this category


The New England journal of medicine, 2025 Feb 05
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia.

Cancers, 2021 Jun 23
Chemoimmunotherapy in the First-Line Treatment of Chronic Lymphocytic Leukaemia: Dead Yet, or Alive and Kicking?

Seminars in hematology, 2023 Dec 26
B-cell receptor immunoglobulin stereotypy in chronic lymphocytic leukemia: Key to understanding disease biology and stratifying patients.

Haematologica, 2020 Nov 01
Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2024 Dec 07
Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.

Related Topics in Internal Medicine

  • Psychiatry
  • Hematology
  • General Outpatient Psychiatry
  • Infectious Disease
  • Cardiology
  • General Infectious Disease
  • General Internal Medicine
  • Dermatology
  • Medical Oncology
  • Advanced Heart Failure and Transplant

Copyright © 2025 theMednet
All Rights Reserved.